Uric acid in Parkinson's disease
作者： Ilana Schlesinger , Naomi Schlesinger
DOI: 10.1002/MDS.22139
关键词:
摘要: Recent studies have provided evidence that uric acid may play a role in the development and progression of Parkinson's disease (PD). Uric is natural antioxidant reduce oxidative stress, mechanism thought to pathogenesis PD. Higher levels serum urate (SU) neuroprotective effect. High SU reduced risk developing PD correlated with slower progression. Among patients were lower as compared controls. The manipulation holds promise treatment It possible high purine diet slow disease. Milk meat consumption well exercise modify possibly through their influence on levels. In this article, we review association between its implication management
sci-hub.se 参考文章(46)
F Niklasson, H Agren, Brain energy metabolism and blood-brain barrier permeability in depressive patients: analyses of creatine, creatinine, urate, and albumin in CSF and blood. Biological Psychiatry. ,vol. 19, pp. 1183- 1206 ,(1984)
K J A Davies, A Sevanian, S F Muakkassah-Kelly, P Hochstein, Uric acid-iron ion complexes. A new aspect of the antioxidant functions of uric acid. Biochemical Journal. ,vol. 235, pp. 747- 754 ,(1986) , 10.1042/BJ2350747
RAYMOND D. STARLING, TODD A. TRAPPE, KEVIN R. SHORT, MELINDA SHEFFIELD-MOORE, ALISON C. JOZSI, WILLIAM J. FINK, DAVID L. COSTILL, Effect of inosine supplementation on aerobic and anaerobic cycling performance Medicine and Science in Sports and Exercise. ,vol. 28, pp. 1193- 1198 ,(1996) , 10.1097/00005768-199609000-00017
M. Park, G. W. Ross, H. Petrovitch, L. R. White, K. H. Masaki, J. S. Nelson, C. M. Tanner, J. D. Curb, P. L. Blanchette, R. D. Abbott, Consumption of milk and calcium in midlife and the future risk of Parkinson disease. Neurology. ,vol. 64, pp. 1047- 1051 ,(2005) , 10.1212/01.WNL.0000154532.98495.BF
S Spitsin, D C Hooper, T Leist, L J Streletz, T Mikheeva, H Koprowski, Inactivation of peroxynitrite in multiple sclerosis patients after oral administration of inosine may suggest possible approaches to therapy of the disease Multiple Sclerosis Journal. ,vol. 7, pp. 313- 319 ,(2001) , 10.1177/135245850100700507
D. T. Dexter, F. R. Wells, A. J. Lee, F. Agid, Y. Agid, P. Jenner, C. D. Marsden, Increased Nigral Iron Content and Alterations in Other Metal Ions Occurring in Brain in Parkinson's Disease Journal of Neurochemistry. ,vol. 52, pp. 1830- 1836 ,(1989) , 10.1111/J.1471-4159.1989.TB07264.X
Roel C van der Veen, David R. Hinton, Francesca Incardonna, Florence M Hofman, Extensive peroxynitrite activity during progressive stages of central nervous system inflammation Journal of Neuroimmunology. ,vol. 77, pp. 1- 7 ,(1997) , 10.1016/S0165-5728(97)00013-1
Tua Annanmaki, Antti Muuronen, Kari Murros, Low plasma uric acid level in Parkinson's disease. Movement Disorders. ,vol. 22, pp. 1133- 1137 ,(2007) , 10.1002/MDS.21502
L. Ma, L. Zhang, X. H. Gao, W. Chen, Y. P. Wu, Y. Wang, X. F. Li, P. Como, K. Kieburtz, Y. L. Qiao, Dietary factors and smoking as risk factors for PD in a rural population in China: a nested case-control study. Acta Neurologica Scandinavica. ,vol. 113, pp. 278- 281 ,(2006) , 10.1111/J.1600-0404.2005.00571.X
J. W. Davis, A. Grandinetti, C. J. Waslien, G. W. Ross, L. R. White, D. M. Morens, Observations on Serum Uric Acid Levels and the Risk of Idiopathic Parkinson's Disease American Journal of Epidemiology. ,vol. 144, pp. 480- 484 ,(1996) , 10.1093/OXFORDJOURNALS.AJE.A008954